Business

Cardax Appoints Global Healthcare Executive as Independent Director

Cardax Appoints Global Healthcare Executive as Independent Director.

articleCardax IncJanuary 10, 20174/company/cardax-inc/news/cardax-appoints-global-healthcare-executive-as-independent-director
Cardax Appoints Global Healthcare Executive as Independent Director

About this update from Cardax Inc

[{"type":"text","content":"\n \n Cardax, Inc. (“Cardax”) (OTCQB:CDXI) announced today the appointment of \n Michele Galen, an attorney and former Chief Communications Officer for \n both Novartis AG and Shire plc, as an independent member of its Board of \n Directors. Ms. Galen will join current Chairman and independent director \n George Bickerstaff, independent director Terence A. Kelly, PhD, and \n Cardax CEO David G. Watumull on the Cardax Board. The appointment was \n made on January 4, 2017.\n \n \n “Michele brings highly successful senior management and communications \n experience from Novartis, Shire, and leading venture capital firm MPM \n Capital to the Cardax Board,” said Chairman George Bickerstaff. \n “Combined with her experience as a journalist and lawyer, Michele offers \n a unique perspective that will further contribute to the achievement of \n our strategy.”\n \n \n “Michele’s broad background, in particular across consumer health and \n pharmaceutical commercialization, provides an ideal skill set for Cardax \n as it commercializes ZanthoSyn™, its safe anti-inflammatory for general \n health, and develops CDX-085, its superior second generation product,” \n said CEO David G. Watumull. “We are delighted to welcome Michele to the \n Cardax Board.”\n \n \n About Michele Galen\n \n \n Michele Galen is a strategic advisor to firms across pharmaceuticals, \n biotech, health start-ups and global health. Ms. Galen served as Global \n Head, Communications and Public Affairs, for Shire plc, serving as the \n lead communications and public affairs advisor on the $32 billion \n successful acquisition and integration of Baxalta. Previously, Ms. Galen \n led Global Communications in Switzerland for Novartis AG, where she \n spent 14 years in positions of increasing responsibility and served on \n several management boards. Earlier, Ms. Galen served as chief marketing \n officer for MPM Capital, Managing Director for public relations firm \n Burson-Marsteller, Legal Affairs Editor for Business Week magazine, and \n an attorney with Skadden, Arps, Slate, Meagher & Flom LLP. Ms. Galen is \n currently a board member for nonprofit Global Oncology and for MK&A, a \n global healthcare consulting firm. Ms. Galen received a B.A. from George \n Washington University, M.S. from th...

More updates from Cardax Inc